Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1126/science.abc4730 http://scihub22266oqcxt.onion/10.1126/science.abc4730 32732280!7574913!32732280     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Science 2020 ; 369 (6511): 1603-1607 Nephropedia Template TP {{tp|p=32732280|t=2020. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy |pdf=|usr=}}{{32732280}} gab.com Text Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy JO: Science http://www.kidney.de/pget.php?&tw=1&pmid=32732280 #FOAvip The ongoing coronavirus disease 2019 (COVID-19) pandemic has prioritized the development of small-animal models for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the respiratory tract of aged BALB/c mice. The resulting mouse-adapted strain at passage 6 (called MASCp6) showed increased infectivity in mouse lung and led to interstitial pneumonia and inflammatory responses in both young and aged mice after intranasal inoculation. Deep sequencing revealed a panel of adaptive mutations potentially associated with the increased virulence. In particular, the N501Y mutation is located at the receptor binding domain (RBD) of the spike protein. The protective efficacy of a recombinant RBD vaccine candidate was validated by using this model. Thus, this mouse-adapted strain and associated challenge model should be of value in evaluating vaccines and antivirals against SARS-CoV-2. Twit Text FOAVip Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy ????Science http://www.kidney.de/pget.php?&tw=1&pmid=32732280 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32732280 #FOAvip English Wikipedia <ref>{{Cite pmid|32732280}}</ref> Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy #MMPMID32732280 Gu H; Chen Q; Yang G; He L; Fan H; Deng YQ; Wang Y; Teng Y; Zhao Z; Cui Y; Li Y; Li XF; Li J; Zhang NN; Yang X; Chen S; Guo Y; Zhao G; Wang X; Luo DY; Wang H; Yang X; Li Y; Han G; He Y; Zhou X; Geng S; Sheng X; Jiang S; Sun S; Qin CF; Zhou Y Science 2020[Sep]; 369 (6511): 1603-1607 PMID32732280show ga The ongoing coronavirus disease 2019 (COVID-19) pandemic has prioritized the development of small-animal models for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the respiratory tract of aged BALB/c mice. The resulting mouse-adapted strain at passage 6 (called MASCp6) showed increased infectivity in mouse lung and led to interstitial pneumonia and inflammatory responses in both young and aged mice after intranasal inoculation. Deep sequencing revealed a panel of adaptive mutations potentially associated with the increased virulence. In particular, the N501Y mutation is located at the receptor binding domain (RBD) of the spike protein. The protective efficacy of a recombinant RBD vaccine candidate was validated by using this model. Thus, this mouse-adapted strain and associated challenge model should be of value in evaluating vaccines and antivirals against SARS-CoV-2. |*Disease Models, Animal[MESH] |*Mice[MESH] |Administration, Intranasal[MESH] |Angiotensin-Converting Enzyme 2[MESH] |Animals[MESH] |Betacoronavirus/genetics/*immunology/pathogenicity[MESH] |COVID-19[MESH] |COVID-19 Vaccines[MESH] |Coronavirus Infections/immunology/*prevention & control[MESH] |Female[MESH] |High-Throughput Nucleotide Sequencing[MESH] |Humans[MESH] |Immunogenicity, Vaccine[MESH] |Lung Diseases, Interstitial/virology[MESH] |Lung/virology[MESH] |Mice, Inbred BALB C[MESH] |Mice, Transgenic[MESH] |Mutation[MESH] |Pandemics/*prevention & control[MESH] |Peptidyl-Dipeptidase A/genetics[MESH] |Pneumonia, Viral/*prevention & control[MESH] |SARS-CoV-2[MESH] |Spike Glycoprotein, Coronavirus/genetics[MESH] |Vaccines, Synthetic/administration & dosage/immunology[MESH] |Viral Vaccines/administration & dosage/*immunology[MESH]Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy (epmc).pdf DeepDyve Pubget Overpricing